Navigation Links
Pharma and food thought leaders set to converge in Amsterdam next April
Date:8/20/2010

Amsterdam, 20 August 2010 - Pharma-Nutrition, the new international scientific conference organised by Elsevier, the leading publisher of scientific, technical and medical information products and services, aims to discuss the latest research, concepts and practical applications of medical nutrition in patient treatments, disease management and patient outcomes. Pharma-Nutrition is set to take place next 18-20 April at Amsterdam's NH Grand Hotel Krasnapolsky. The convergence of both pharmacology and food science professionals, will make this the first platform dedicated to the scientific interface between pharma and food.

The Scientific Committee composed of acknowledged opinion leaders in both food science and pharmacology from across the spectrum of therapeutic research areas will work alongside organisers to develop a multidisciplinary programme, covering areas such as oncology, immunology, neurology and cardiovascular disease. The Conference Chairman, Professor Johan Garssen, University of Utrecht, commented, "We are starting to see a real convergence of the two areas of pharma and food and it is their complementary values which can be applied to medical nutrition in order to help address the ever growing burden of diseases in modern society."

"I am so pleased that we have been able to bring together for the first time such an outstanding group of preclinical and clinical experts from both pharma and nutrition," said Dr. Jaap van Harten, Elsevier Executive Publisher. "This conference will provide the platform for participants to share and discuss their latest research on this important area of science," he remarked.


'/>"/>

Contact: Rachel Martin
r.martin@elsevier.com
31-020-485-2467
Elsevier
Source:Eurekalert

Page: 1

Related biology news :

1. CoLucid Pharmaceuticals, Inc. announces study data documenting oral efficacy of lasmiditan (COL-144), a selective 5-HT1F receptor agonist, in the treatment of acute migraine attacks
2. Pitt pharmacologists go on a molecular fishing trip and hook prize catch
3. ACS Green Chemistry Institute Pharmaceutical Roundtable award goes to Scottish chemist
4. ViroPharma Announces Initiation of Phase 2 Evaluation of Subcutaneous Delivery of Cinryze(TM) (C1 Esterase Inhibitor [Human])
5. Biostar Pharmaceuticals, Inc. Receives New Advertising Approval from Shaanxi SFDA for Marketing Xin Aoxing Capsule
6. URI pharmacy researcher finds beneficial compounds in pure maple syrup
7. NIH awards $8.5 million for research on pharmaceuticals for children
8. TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services
9. GREENBioPharma -- Dec. 2-3, 2009
10. ERGONEX Pharma receives Frost & Sullivans European Orphan Diseases Entrepreneurial Company Award 2009
11. TAXIS Pharmaceuticals licenses novel antimicrobial technology from Rutgers and UMDNJ
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/14/2016)... , Nov. 14, 2016  Based on ... market, Frost & Sullivan recognizes FST Biometrics ... Award for Visionary Innovation Leadership. FST Biometrics ... biometric identification market by pioneering In Motion ... for instant, seamless, and non-invasive verification. This ...
(Date:6/22/2016)... ANGELES , June 22, 2016 /PRNewswire/ ... identity management and verification solutions, has partnered ... edge software solutions for Visitor Management, Self-Service ... provides products that add functional enhancements ... partnership provides corporations and venues with an ...
(Date:6/20/2016)... 20, 2016 Securus Technologies, a leading ... for public safety, investigation, corrections and monitoring announced ... it has secured the final acceptance by all ... Managed Access Systems (MAS) installed. Furthermore, Securus will ... be installed by October, 2016. MAS distinguishes between ...
Breaking Biology News(10 mins):
(Date:12/6/2016)... Albany, NY (PRWEB) , ... December 06, 2016 ... ... system integrator of custom industrial automation and IT solutions, today announced the company ... Controls has reliably delivered professionally executed automation and control systems integration services to ...
(Date:12/6/2016)... Ind. , Dec. 6, 2016 Zimmer ... "Company") today announced the pricing terms of its ... to $1.25 billion aggregate purchase price (excluding accrued and ... settlement date and excluding fees and expenses related ... the debt securities identified in the table below ...
(Date:12/5/2016)... 5, 2016 Axovant Sciences Ltd. (NYSE: ... on the treatment of dementia, today announced that data ... of Alzheimer,s disease will be presented at the 2016 ... December 9, 2016 in San Diego ... both simple and complex measures of activities of daily ...
(Date:12/5/2016)... 2016 According to the ... Products (Consumable, Instruments, Automated Cell Expansion System), Cells ... Cell Research, Cancer, and Cell-Based Research), End-users (Biopharmaceutical ... Global Revenue, Trends, Growth, Share, Size and Forecast ... global cell expansion market is expected to reach ...
Breaking Biology Technology: